We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 44

Sidley Austin LLP global pricing newsletter - volume three 2014

  • Sidley Austin LLP
  • -
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • -
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare

2013 antitrust developments for insurance companies

  • DLA Piper LLP
  • -
  • USA
  • -
  • February 13 2014

Insurers and reinsurers are often involved in collective action, either in co-ventures or by government edict. At the same time, any collaboration

District Court dismisses antitrust action against Highmark and UPMC

  • McGuireWoods LLP
  • -
  • USA
  • -
  • October 16 2013

On September 27, the U.S. District Court for the Western District of Pennsylvania dismissed plaintiffs' complaint in Royal Mile Co. v. UPMC, which

Court dismisses challenge to prescription drug copayment coupon program

  • Hunton & Williams LLP
  • -
  • USA
  • -
  • June 6 2013

On June 3, 2013, the US District Court for the Southern District of New York dismissed a putative class action alleging that a prescription drug

BCBS of MI antitrust case dropped

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • April 2 2013

On March 25, the U.S. Department of Justice (DOJ) and the State of Michigan agreed to dismiss an antitrust case against Blue Cross Blue Shield of

Do not pass go, do not collect $200: Michigan statute and regulatory order banning MFN provisions in provider contracts ends government antitrust lawsuit against Michigan Blue

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • March 26 2013

In the wake of the passage of a Michigan statute and regulatory order banning the use of most favored nation ("MFN") clauses by insurers, health

Federal government to launch multistate health insurance plans

  • Barnes & Thornburg LLP
  • -
  • USA
  • -
  • November 1 2012

Under multistate plans recently announced by the Obama administration, health insurance operated under contract with the federal government will be available to consumers in every state through state insurance exchanges mandated under the Affordable Care Act

DOJ continues scrutiny of MFN provisions

  • McGuireWoods LLP
  • -
  • USA
  • -
  • June 25 2012

Recent actions by the U.S. Department of Justice's Antitrust Division involving "most favored nation" provisions include: this month it was widely reported that the Antitrust Division is currently investigating alleged anticompetitive practices in the cable industry, including whether cable companies are using MFNs in agreements with television networks to quash competition from online rivals

Recent lawsuits allege anticompetitive market allocation conspiracy by Blue Cross and Blue Shield

  • King & Spalding LLP
  • -
  • USA
  • -
  • April 24 2012

Two recent lawsuits allege that Blue Cross and Blue Shield entities in North Carolina and Alabama have violated federal and state antitrust laws by engaging in concerted action with other Blue Cross Blue Shield (BCBS) plans nationwide to divide geographic markets among them, which has allegedly resulted in reduced competition and higher rates charged to end customers for healthcare services

District Court dismisses follow-on suit challenging Blue Cross's "MFN-Plus' contracts under both per se and rule of reason standards

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • USA
  • -
  • April 11 2012

The District Court for the Eastern District of Michigan recently dismissed antitrust claims brought by the City of Pontiac against Blue Cross Blue Shield of Michigan's practice of requiring hospitals to enter into "MFN-Plus" contracts, which was alleged to have significantly raised prices to Blue Cross's competitors